-
Notifications
You must be signed in to change notification settings - Fork 11
Description
can you clarify what you mean by the 'biological' begin/end position to use in your model?
there are a couple of ways that could be interpreted from the current documentation:
- the begin/end of where transcription starts/ends
- the begin/end of the resulting (active) form of the product of transcription and/or translation.
when strandedness is known, option 1 would work for all cases, but option 2 is confusing if you are talking about miRNAs and other RNA products where the active form is the complement, and thus for an RNA-gene on the negative strand means the two-negatives-make-a-positive would need to be applied based on the feature type.
furthermore, when it is a region bound by two BothStrandPosition what is the biological start/end? Is that intended to default to start < end, but either could be valid? Is it then up to the consumer of the data to reconcile that there could be two equivalent regions where the start/ends are switched?